Your browser doesn't support javascript.
loading
A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML.
Knapper, Steven; Russell, Nigel; Gilkes, Amanda; Hills, Robert K; Gale, Rosemary E; Cavenagh, James D; Jones, Gail; Kjeldsen, Lars; Grunwald, Michael R; Thomas, Ian; Konig, Heiko; Levis, Mark J; Burnett, Alan K.
Affiliation
  • Knapper S; Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Russell N; Department of Haematology, Nottingham University Hospital, Nottingham, United Kingdom.
  • Gilkes A; Experimental Cancer Medicine Centre, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Hills RK; Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.
  • Gale RE; Department of Haematology, University College London Cancer Institute, London, United Kingdom; Department of Haematology, Bart's Health NHS Trust, London, United Kingdom.
  • Cavenagh JD; Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Jones G; Department of Haematology, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom.
  • Kjeldsen L; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.
  • Thomas I; Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.
  • Konig H; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; and.
  • Levis MJ; Division of Hematological Malignancies, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD.
  • Burnett AK; Department of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom.
Blood ; 129(9): 1143-1154, 2017 03 02.
Article in En | MEDLINE | ID: mdl-27872058

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbazoles / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Fms-Like Tyrosine Kinase 3 Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbazoles / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Fms-Like Tyrosine Kinase 3 Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2017 Document type: Article Affiliation country: United kingdom Country of publication: United States